Human B. Lymphoblastoid cell, hybridoma, antibody and production

Details Human B. Lymphoblastoid cell, hybridoma, antibody and production Human B. Lymphoblastoid cell, hybridoma, antibody and production

1988-12-19

1992-06-30

Doll, John

Chemistry: molecular biology and microbiology

Spore forming or isolating process

C12N 512

Patent

active

051262592

ABSTRACT:
The present invention provides human B lymphoblastoid cell line AC-33, which is novel, and excellent in proliferativity and fusion capability, and works well as the parental line for obtaining a human monoclonal antibody-producing hybridoma. Said hybridoma possesses excellent proliferativity and stable antibody productivity, thus permitting efficient antibody production over a long period.

REFERENCES:
Chemical Abstracts, 100:207654v.
Ichimori et al., Biochemical and Biophysical Research Communications, vol. 142, No. 3, 1987, pp. 805-812.
Y. Shintani et al.; Text for Fourth Symposium on Research and Development Project of Basic Technology for Future Industries, p. 51 (1986).
Chemical Patents Index, Country Alerting Bulletin, Section, D, 88-143402/21 J63084-488-A.

Affiliated with

Also associated with

Rating

Human B. Lymphoblastoid cell, hybridoma, antibody and production does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Human B. Lymphoblastoid cell, hybridoma, antibody and production, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human B. Lymphoblastoid cell, hybridoma, antibody and production will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1863345